Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Urinary Biomarkers for the Detection of Breast Cancer

NCT05453591 is registered in ClinicalTrials.gov with Novosanis NV as lead sponsor.

NCT NCT05453591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05453591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Urinary Biomarkers for the Detection of Breast Cancer
Lead sponsor
Novosanis NV
Phase
Not applicable
Overall status
Unknown status
Start date
December 21, 2022
Completion date
April 30, 2024
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, liquid biopsy, urine